FDA Licenses Blood Grouping Reagents for Extended Phenotype Testing: ORTHO™ Sera Featured in CLP

FDA Licenses Blood Grouping Reagents for Extended Phenotype Testing: ORTHO™ Sera Featured in CLP

Sep 26, 2017

“Ortho Sera helps increase confidence in the lab and allow staff to focus on improving lab efficiency,” says Robert Yates, chief operating officer at Ortho.

 

 
© Ortho Clinical Diagnostics 2019. Ortho Clinical Diagnostics, publishes this site and is solely responsible for its content. The availability of the products is subject to compliance with the regulatory requirements of each market.
${loading}